Navigation Links
Intellisphere Announces Acquisition of Multiple Titles from Ascend Media's Healthcare Division
Date:2/4/2008

e-media solution provider."

Intellisphere is the publisher of the award-winning MDNG (http://www.mdng.com) franchise of medical magazines, as well as a variety of online properties, supplements, and journals, including OncNG (Oncology Net Guide) and OncNG: Nurses Edition. Collectively, the titles in the Intellisphere family are read by more than a quarter of a million physicians and allied healthcare professionals within multiple specialties, including primary care, cardiology, endocrinology, neurology, oncology, pediatrics, psychiatry, and hospital medicine.

"The acquisition of the Ascend titles accelerates our commitment to new markets," Hennessy commented. "By expanding our reach in the areas of cardiovascular medicine, pharmacy medicine, internal medicine, family practice, managed care, surgical medicine, and personal finance for physicians, we provide a potent array of options and channels for our readers and marketers who are looking to target specific healthcare audiences."

About Intellisphere

A pioneer in the integration of print and Internet media, Intellisphere, LLC is the publisher of the award-winning series of MDNG journals, custom publications, websites, and e-mail newsletters (eDigests). Published in nine editions with a unique, contemporary voice, style, and look, MDNG explores technology, computers, and the Internet, from the very practical to the most sophisticated, and the impact they have on the professional and personal life of the physician. Connecting more than a quarter of a million physicians and specialists to current and emerging healthcare technology trends, hundreds of online resources, and the latest breakthroughs affecting their medical practice, the MDNG series of publications, sites, and custom products have continually profiled the best online content for physicians, patients, and their caregivers.


'/>"/>
SOURCE Intellisphere
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NeoStrata(R) Announces the Launch of PSORENT(TM) Psoriasis Topical Treatment
2. Remergent(R) Announces the Launch of Four New Products Pioneers of DNA Repair Expand Anti-Aging Line
3. Centocor Announces Ustekinumab Biologic License Application Accepted for Filing by FDA
4. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
5. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
6. Medarex Announces Completion of Sale of Shares in Genmab A/S
7. Eisai Announces Change in U.S. Submission Schedule for E7389 New Drug Application
8. Rigel Announces Pricing of Public Offering of Common Stock
9. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
10. Healthcare Technologies Ltd. Announces the Change of its Name to "NexGen Biofuels Ltd"
11. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... April 30, 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) ... of 2015 were $4.4 million, compared to $8.0 million during ... the first quarter was $8.9 million, or $0.23 per basic ... for the same period in 2014, of $8.7 million, or ... 31, 2015, cash, cash equivalents and investments totaled $117.5 million. ...
(Date:4/30/2015)... Nitto Avecia, a leading biotechnology manufacturer and ... production capability to serve biotechnology pharmaceutical clients. A ... continues to drive Nitto Avecia to enhance synthesis ... , In Fall 2014, Nitto Avecia first ... its Milford, MA facility, which is recognized as ...
(Date:4/30/2015)... , April 30, 2015 The following is an ... Directors of China Cord Blood Corp (NYSE: CO ) ... committee of the independent directors of China Cord Blood Corp ... offer of $6.40 per share from Golden Meditech Holdings Co ... per share would greatly benefit Golden Med and Mr. Kam, ...
(Date:4/30/2015)...  The Paul G. Allen Family Foundation announced today ... six groups of researchers with projects at the frontier ... growing mature human brain cells in the laboratory. The ... over three years.  "This new cohort ... significant because the field of neuronal maturation is at ...
Breaking Biology Technology:Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 4April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 5The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 3The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 4The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 5
... MedPredict has published,"Thought Leader Insight & Analysis: Alzheimer,s ... and biotech companies with a,stake in the market ... "Given the size of this patient population ... control, it is not surprising to see the,large ...
... Therapy Better Option for Humans, EGG HARBOR ... the first time, The British Institute of Homeopathy, ... to U.S. medical and,homeopathic practitioners for a low-introductory ... cell therapy is more advantageous because,it does not ...
... 28 Carl Icahn confirmed today that,entities affiliated with ... to nominate three persons at Biogen,s forthcoming 2008 Annual,Meeting ... currently,has a staggered board of twelve directors, and there ... Icahn stated that "We are taking this action because ...
Cached Biology Technology:New Report Tackles the Changing Landscape for Alzheimer's Diagnostics and Treatments 2Icahn Confirms Intention to Nominate Three Directors at Biogen 2Icahn Confirms Intention to Nominate Three Directors at Biogen 3
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... of the "Global Iris Recognition Market 2015-2019" ... the Global Iris Recognition market to grow at a ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... study has confirmed that research done with zebrafish may be ... genetic basis of cancer and the mutations that can lead ... whose function is essential to preventing tumors. , The findings ... Academy of Sciences, by researchers from Oregon State University and ...
... of how humans differ from one another at the DNA ... recent evolution of our species, according to researchers from Cornell ... study published in the Oct. 20 issue of the journal ... not only among 39 humans but also between the humans ...
... a UN report provides definitive answers and ways to repair ... could eventually die of radiation exposure from the Chernobyl nuclear ... team of more than 100 scientists has concluded. , As ... attributed to radiation from the disaster, almost all being highly ...
Cached Biology News:Zebrafish may hold key to improved cancer research 2Zebrafish may hold key to improved cancer research 3Cornell finds natural selection in humans 2Cornell finds natural selection in humans 3Chernobyl: The true scale of the accident 2Chernobyl: The true scale of the accident 3Chernobyl: The true scale of the accident 4Chernobyl: The true scale of the accident 5Chernobyl: The true scale of the accident 6Chernobyl: The true scale of the accident 7Chernobyl: The true scale of the accident 8Chernobyl: The true scale of the accident 9Chernobyl: The true scale of the accident 10Chernobyl: The true scale of the accident 11Chernobyl: The true scale of the accident 12Chernobyl: The true scale of the accident 13Chernobyl: The true scale of the accident 14Chernobyl: The true scale of the accident 15Chernobyl: The true scale of the accident 16
... off-white solid. A nucleoside antibiotic that ... formation of N-glycosidic protein-carbohydrate linkages. Active ... bacteria, yeasts, fungi, and viruses. Inhibits ... on human T-lymphoblastoid cells. Also inhibits ...
... The UltraRocker rocking platform, 120 V, is used ... incubation of liquid cultures, staining and destaining of ... features variable speed control (8-40 rpm) and can ... lb). The rocker features two 29 x 21 ...
Mouse monoclonal antibody to DCAMKL2 - doublecortin and CaM kinase-like 2...
...
Biology Products: